{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:34:27Z","timestamp":1788878067269,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Proliferative glomerulonephritis with monoclonal immunoglobulin G (IgG) deposits (PGNMID) is a disease entity with nonorganized granular glomerular deposition with monoclonal proteins of both heavy and light chains. Dysproteinemia was observed in only 30% of the patients with PGNMID. We herein report a case of PGNMID with discrepancy between serum and glomerular deposits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a 50-year-old man who had been followed at a local clinic due to hypertension, type 2 diabetes, hyperlipidemia, hyperuricemia, fatty liver, and obesity. Proteinuria had been noted five years previously, and he had been referred to a hematology department due to hyperproteinemia, high gamma globulin, and \u03ba Bence-Jones protein (BJP) positivity one year previously. Bone marrow aspiration showed 5% plasma cells, and he was referred to the nephrology department to evaluate persistent proteinuria. He was hypertensive, and his estimated glomerular filtration rate was 54.2 ml\/min\/1.73 m<jats:sup>2<\/jats:sup>. His urinary protein level was 0.84\u00a0g\/g\u22c5Cr. Urine and serum immunofixation showed BJP-\u03ba type and IgG-\u03ba type, respectively. Kidney biopsy showed an increase in mesangial cells and matrix without nodular lesions under a light microscope. Immunofluorescence microscopy showed granular deposits of IgG and C3 on the capillary wall and weak positivity for C1q. IgG3 was predominant among the IgG subclasses, and intraglomerular \u03ba and \u03bb staining was negative for \u03ba and positive for \u03bb. Direct fast scarlet staining was negative. Electron microscopy showed lumpy deposits without a fibrillar structure in the subepithelial area. Based on the above findings, a diagnosis of membranous nephropathy-type PGNMID was made. Since proteinuria increased gradually after three years of treatment with valsartan (40\u00a0mg, daily), oral prednisolone (30\u00a0mg, daily) was initiated, which led to decreased proteinuria. The dose of oral prednisolone was gradually tapered to 10\u00a0mg per day. At that time, proteinuria was 0.88\u00a0g\/g\u22c5Cr. We found 204 cases in 81 articles in the PubMed database, among which 8 showed discrepancy in the heavy and\/or light chains between serum and kidney.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We experienced a case of membranous nephropathy-type PGNMID with discrepancy in light chains between serum and kidney that was successfully treated with oral prednisolone.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03256-5","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T09:02:34Z","timestamp":1688202154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature"],"prefix":"10.1186","volume":"24","author":[{"given":"Shoko","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-133X","authenticated-orcid":false,"given":"Kan","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumika","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"1","key":"3256_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","volume":"65","author":"SH Nasr","year":"2004","unstructured":"Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65(1):85\u201396. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00365.x.","journal-title":"Kidney Int"},{"issue":"9","key":"3256_CR2","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2009010110","volume":"20","author":"SH Nasr","year":"2009","unstructured":"Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20(9):2055\u201364. https:\/\/doi.org\/10.1681\/ASN.2009010110.","journal-title":"J Am Soc Nephrol"},{"key":"3256_CR3","first-page":"846","volume":"32","author":"MD Redondo-Pach\u00f3n","year":"2012","unstructured":"Redondo-Pach\u00f3n MD, Enr\u00edquez R, Sirvent AE, Andrada E, Garc\u00eda-Del Moral R, Mill\u00e1n I, et al. Proliferative glomerulonephritis with monoclonal IgG deposits on multiple myeloma. Nefrologia. 2012;32:846\u20138.","journal-title":"Nefrologia"},{"issue":"2","key":"3256_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1053\/j.ajkd.2013.07.015","volume":"63","author":"I Batal","year":"2014","unstructured":"Batal I, Bijol V, Schlossman RL, Rennke HG. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a kidney allograft. Am J Kidney Dis. 2014;63(2):318\u201323. https:\/\/doi.org\/10.1053\/j.ajkd.2013.07.015.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3256_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.kint.2016.10.026","volume":"91","author":"M Vignon","year":"2017","unstructured":"Vignon M, Cohen C, Faguer S, Noel LH, Guilbeau C, Rabant M, et al. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. Kidney Int. 2017;91(3):720\u20138. https:\/\/doi.org\/10.1016\/j.kint.2016.10.026.","journal-title":"Kidney Int"},{"key":"3256_CR6","first-page":"1027376","volume":"2017","author":"H Shimohata","year":"2017","unstructured":"Shimohata H, Ohgi K, Maruyama H, Miyamoto Y, Takayashu M, Hirayama K, et al. A case of proliferative glomerulonephritis with monoclonal IgG deposits that showed predominantly membranous features. Case Rep Nephrol. 2017;2017:1027376.","journal-title":"Case Rep Nephrol"},{"issue":"1","key":"3256_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","volume":"94","author":"R Gumber","year":"2018","unstructured":"Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, et al. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int. 2018;94(1):199\u2013205. https:\/\/doi.org\/10.1016\/j.kint.2018.02.020.","journal-title":"Kidney Int"},{"key":"3256_CR8","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.ekir.2021.05.011","volume":"6","author":"JL Rosenstock","year":"2021","unstructured":"Rosenstock JL, Vynnyk M, DeVita MV, D\u2019Agati VD. Two cases of proliferative glomerulonephritis with monoclonal IgG deposits treated with renin angiotensin inhibition alone with long-term follow-up. Kidney Int Rep. 2021;6:2218\u201322.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"3256_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfz176","volume":"36","author":"F Bridoux","year":"2021","unstructured":"Bridoux F, Javaugue V, Nasr SH, Leung N. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective. Nephrol Dial Transplant. 2021;36(2):208\u201315. https:\/\/doi.org\/10.1093\/ndt\/gfz176.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3256_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13730-013-0064-3","volume":"2","author":"R Ohashi","year":"2013","unstructured":"Ohashi R, Sakai Y, Otsuka T, Ohno D, Masuda Y, Murasawa T, et al. Proliferative glomerulonephritis with monoclonal IgG2\u03ba deposit successfully treated with steroids: a case report and review of the literature. CEN Case Rep. 2013;2(2):197\u2013203. https:\/\/doi.org\/10.1007\/s13730-013-0064-3.","journal-title":"CEN Case Rep"},{"key":"3256_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2215\/CJN.10611110","volume":"6","author":"E Guiard","year":"2011","unstructured":"Guiard E, Karras A, Plaisier E, Van Duong JP, Fakhouri F, Rougier JP, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol. 2011;6:1609\u201316.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3256_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"3256_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698\u2013711. https:\/\/doi.org\/10.1038\/ki.2014.408.","journal-title":"Kidney Int"},{"issue":"1","key":"3256_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45\u201359. https:\/\/doi.org\/10.1038\/s41581-018-0077-4.","journal-title":"Nat Rev Nephrol"},{"key":"3256_CR15","doi-asserted-by":"publisher","first-page":"608741","DOI":"10.3389\/fmed.2021.608741","volume":"8","author":"G Hirose","year":"2021","unstructured":"Hirose G, Uchida T, Kojima A, Sugisaki K, Yamada M, Nagase Y, et al. Membranous Nephropathy with Monoclonal IgM Lambda deposits in a patient with IgM Monoclonal Gammopathy: a Case Report. Front Med (Lausanne). 2021;8:608741.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03256-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03256-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03256-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T09:05:46Z","timestamp":1688202346000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03256-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3256"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03256-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report. A copy of the written consent is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}